Late dumping syndrome presents in the postprandial window as symptomatic reactive hypoglycaemia. When blood glucose falls to critically low levels in this period, a specific pharmacological approach is indicated.

Clinical Scenario

Late dumping syndrome typically occurs 1–3 hours after a meal and is characterised by reactive hypoglycaemia. Diagnosis is confirmed when the late postprandial nadir glucose falls below 50 mg/dl — a threshold used in modified oral glucose tolerance testing to identify this form of dumping.

Treatment Approach

For patients with well-established late dumping syndrome, somatostatin analogues represent the preferred pharmacological treatment direction. This class includes both short-acting and long-acting formulations; the complete protocol specifies the available options and the appropriate administration for each.

Full regimen details — formulations, schedules, and sequencing — are available in the structured protocol below.

References

DOI: 10.1038/s41574-020-0357-5

Late dumping syndrome usually occurs 1–3 h after a meal and is characterized by (reactive) hypoglycaemia.
The modified OGTT is considered positive for late dumping syndrome based on the development of late (60–180 min after ingestion) hypoglycaemia (<50 mg/dl).
Somatostatin analogues are the preferred treatment option for patients with well-established dumping syndrome who do not respond to initial dietary modification with or without acarbose treatment.

View source ↗

Treatment of Late Dumping Syndrome with Reactive Hypoglycaemia Occurring 1–3 Hours After a Meal

References